Navigation Links
Children's Hospital Cancer Study Finds Adolescents and Young Adults Don't Get Same Access to Cutting-Edge Treatment as Younger Patients
Date:1/15/2008

PITTSBURGH, Jan. 15 /PRNewswire/ -- The overall survival rate from cancer now is lower in older adolescents and young adults with cancer than in younger children, in part because of a lack of access to clinical trials nationally for the older age group, according to a study by pediatric oncologists at Children's Hospital of Pittsburgh of UPMC.

Nationally, cure rates in children younger than 15 with cancer have improved dramatically over the last 30 years, increasing from 60 percent to approximately 85 percent at five years from the time of diagnosis. In contrast, similar improvements in survival rates have not been seen in adolescents and young adults ages 15-22, with cure rates remaining steady at approximately 70 percent throughout the same time period.

This can be attributed to the fact that adolescents and young adults don't have the same access to cutting-edge cancer treatments provided though clinical trials, according to the study led by Peter Shaw, MD, a pediatric hematologist/oncologist at Children's Hospital and the director of the hospital's Adolescent and Young Adult (AYA) Oncology Program.

The study is published in the December issue of the Journal of Pediatric Hematology/Oncology.

"Research has shown that patients who are enrolled in clinical trials offering the most advanced cancer treatments do better than patients who receive conventional treatment," Dr. Shaw said. "Adolescents and young adults with cancer are less likely than younger children to be enrolled in clinical trials for two important reasons: the first factor is that AYA patients are frequently treated by adult oncologists at hospitals that aren't participating in clinical trials designed for cancers occurring in the pediatric and adolescent age groups. Our study demonstrated the second reason, which is that nationally, there are many more clinical trials available for the types of malignancies that most often occur in the younger patients

Drs. Shaw and study co-author A. Kim Ritchey, MD, chief of the Division of Pediatric Hematology/Oncology at Children's and vice chair of Clinical Affairs in the Department of Pediatrics, studied 640 new oncology patients treated at Children's between July 1, 2001, and June 30, 2006. The patients ranged in age from birth to 22 years old. The study found that:

-- 38 percent of patients younger than 15 were enrolled in a clinical

trial.

-- 27 percent of AYA patients were enrolled in a clinical trial.

-- 41 percent of patients younger than 15 were not treated on a clinical

trial because one was not available.

-- 57 percent of AYA patients were not treated on a clinical trial because

one was not available.

"These findings underscore the need for AYA patients to be treated at centers such as children's hospitals that are involved in national cooperatives offering clinical trials of new treatments for pediatric and adolescent cancers," Dr. Ritchey said. "There also is a need for more national trials to be opened for AYA patients and the types of malignancies most common to them."

The national Children's Oncology Group -- of which Children's is a member -- has an AYA subcommittee on which Dr. Shaw serves that currently is evaluating the types of cancers affecting AYA patients and ways to increase clinical trials available to these patients, according to Drs. Shaw and Ritchey.

One strategy for ensuring that AYA patients are treated by oncologists who are most up-to-date on clinical trials and cutting-edge treatment programs is for pediatric oncology divisions to establish AYA oncology programs in cooperation with adult oncology counterparts.

In 2006, Children's partnered with colleagues from the University of Pittsburgh Cancer Institute to establish an unparalleled AYA Oncology Program. It combines the latest and most effective treatment options with a comprehensive family-centered approach to care that addresses the physical, psychological and emotional needs of adolescents and young adults diagnosed with cancer.

For more information on Children's AYA Oncology Program, visit http://www.chp.edu/aya.


'/>"/>
SOURCE Children's Hospital of Pittsburgh of UPMC
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. DuPont Provides Technology for Washington Hospital Centers Emergency Department
2. Hospital Launches Landmark Emergency Medicine Project
3. Harris Methodist Fort Worth Hospital Using Bubbles to Help Babies Breathe
4. Study Shows That Low-Molecular Weight Heparin (LMWH) was Associated with Reduced Hospital Costs of Venous Thromboembolism (VTE) Treatment Compared with Unfractionated Heparin (UFH)
5. Bristol-Myers Squibb, New Jersey Childrens Hospital Launch Center for Immune System Disorders & Infectious Diseases Including HIV/AIDS
6. Peregrine Announces Addition of The Johns Hopkins Hospital as Study Site for Bavituximab Trial in HCV Patients Co-Infected With HIV
7. Allegheny General Hospital Performs First Liver Transplant
8. Providence Hospital Study Finds Communication System Leads to Faster Heart Attack Treatment
9. Arizona Heart Hospital Reaches Settlement Regarding Clinical Research Matter
10. Hospital to Hold MRSA Briefing for Media and Community Leaders
11. Cardinal Health Releases New Tool to Combat MRSA Infections in Hospitals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... , Feb. 21, 2017  International Isotopes Inc. ... a private placement with certain investors for approximately $3.4 ... the Company, Series C Convertible Redeemable Preferred Stock (the ... at an annual rate of 6% and is convertible ... plans to use the proceeds for operating capital, to ...
(Date:2/21/2017)... , February 21, 2017 According to a new ... Systems (Surgical Robots, Rehabilitation Robots, Hospital Robots, Non-invasive Surgery Robots)), Application (Orthopedic, Laparoscopy, ... Continue Reading ... MarketsandMarkets Logo ... This report studies the global ...
(Date:2/21/2017)... Feb. 21, 2017 Research and Markets has announced ... Global Strategic Business Report" report to their offering. ... The report provides separate comprehensive analytics for ... Europe , Asia-Pacific , ... are provided for the period 2015 through 2022. Also, a six-year historic ...
Breaking Medicine Technology:
(Date:2/21/2017)... ... , ... Ray Insurance Agencies, a Dallas area firm providing asset protection services ... a six month charity event aimed at raising local support and donations that will ... the deadliest diseases in America; more than 7.5 million people die from cancer related ...
(Date:2/21/2017)... ... February 21, 2017 , ... ... clinical trial solutions, today announced the further expansion of its eHealth App ... can leverage as part of Bioclinica’s extensive and growing eHealth platform. Applications ...
(Date:2/21/2017)... Francisco, California (PRWEB) , ... February 21, 2017 ... ... the world with over 50,000 participants. The connected care demonstration spanned multiple ... of the National Coordinator, roughly 30% of providers have no Health Information Exchange ...
(Date:2/21/2017)... ... February 21, 2017 , ... CLICKco LLC, ... announced its products are now available for purchase on RonnieColemanNutrition.com, a popular website ... become popular among health-conscious consumers who love coffee but are looking to add ...
(Date:2/20/2017)... ... 20, 2017 , ... MRI screening improves early diagnosis of breast cancer in ... online in the journal Radiology . , MRI has long been known ... ultrasound. Currently, guidelines reserve breast MRI screening for women who have a strong family ...
Breaking Medicine News(10 mins):